Microbiome in Inflammatory Lung Diseases

Gaurav Gupta; Brian G. Oliver; Kamal Dua; Alisha Singh; Ronan MacLoughlin

doi:10.1007/978-981-16-8957-4

Microbiome in Inflammatory Lung Diseases

Gaurav Gupta
, Brian G. Oliver
, Kamal Dua
, Alisha Singh
, Ronan MacLoughlin

Suresh Gyan Vihar University
University of Technology Sydney
Aerogen

Research output: Book/Report › Book › peer-review

2 Scopus citations

Abstract

This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical and clinical sciences, and pulmonary clinicians.

Original language	English
Publisher	Springer Nature
Number of pages	377
ISBN (Electronic)	9789811689574
ISBN (Print)	9789811689567
DOIs	https://doi.org/10.1007/978-981-16-8957-4
State	Published - 1 Jan 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Inflammation
Inflammatory Cytokines
Lung Cancer
Lung diseases
Microbiome

Access to Document

10.1007/978-981-16-8957-4

Cite this

@book{782cfc60a5cc40e1badca6853138e297,

title = "Microbiome in Inflammatory Lung Diseases",

abstract = "This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical and clinical sciences, and pulmonary clinicians.",

keywords = "Inflammation, Inflammatory Cytokines, Lung Cancer, Lung diseases, Microbiome",

author = "Gaurav Gupta and Oliver, \{Brian G.\} and Kamal Dua and Alisha Singh and Ronan MacLoughlin",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd. 2022, corrected publication 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-981-16-8957-4",

language = "English",

isbn = "9789811689567",

publisher = "Springer Nature",

}

TY - BOOK

T1 - Microbiome in Inflammatory Lung Diseases

AU - Gupta, Gaurav

AU - Oliver, Brian G.

AU - Dua, Kamal

AU - Singh, Alisha

AU - MacLoughlin, Ronan

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd. 2022, corrected publication 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical and clinical sciences, and pulmonary clinicians.

AB - This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical and clinical sciences, and pulmonary clinicians.

KW - Inflammation

KW - Inflammatory Cytokines

KW - Lung Cancer

KW - Lung diseases

KW - Microbiome

UR - https://www.scopus.com/pages/publications/85163498805

U2 - 10.1007/978-981-16-8957-4

DO - 10.1007/978-981-16-8957-4

M3 - Book

AN - SCOPUS:85163498805

SN - 9789811689567

BT - Microbiome in Inflammatory Lung Diseases

PB - Springer Nature

ER -

Microbiome in Inflammatory Lung Diseases

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this